"Prothrombin Time" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS.
| Descriptor ID |
D011517
|
| MeSH Number(s) |
E01.370.225.625.115.610 E05.200.625.115.610 G09.188.680
|
| Concept/Terms |
Prothrombin Time- Prothrombin Time
- Prothrombin Times
- Time, Prothrombin
- Times, Prothrombin
|
Below are MeSH descriptors whose meaning is more general than "Prothrombin Time".
Below are MeSH descriptors whose meaning is more specific than "Prothrombin Time".
This graph shows the total number of publications written about "Prothrombin Time" by people in this website by year, and whether "Prothrombin Time" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 0 | 2 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 3 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 1 | 2 |
| 2013 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prothrombin Time" by people in Profiles.
-
Comparison of warfarin therapy clinical outcomes following implementation of an automated mobile phone-based critical laboratory value text alert system. BMC Med Genomics. 2014; 7 Suppl 1:S13.
-
Evaluation of the International Society on Thrombosis and Haemostasis and institutional diagnostic criteria of disseminated intravascular coagulation in pediatric patients. Am J Clin Pathol. 2013 Jun; 139(6):812-6.
-
Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome. J Pediatr Hematol Oncol. 2010 Oct; 32(7):532-6.
-
Imatinib mesylate (gleevec) hepatotoxicity. Dig Dis Sci. 2007 Feb; 52(2):598-601.
-
Ancylostoma caninum anticoagulant peptide: cloning by PCR and expression of soluble, active protein in E. coli. Mol Biochem Parasitol. 1996 Sep; 80(1):113-7.
-
Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc Natl Acad Sci U S A. 1995 Jun 20; 92(13):6152-6.
-
Effect of aprotinin on transfusion requirements during repeat sternotomy for cardiac transplantation surgery. Transplant Proc. 1994 Dec; 26(6):3719-21.
-
Assessment of factors II, VII, IX, X, and protein C in hepatosplenic schistosomiasis. Haemostasis. 1994 Jan-Feb; 24(1):22-6.
-
Secretion of a proteolytic anticoagulant by Ancylostoma hookworms. J Exp Med. 1983 May 01; 157(5):1594-603.